ANDREW C. VON ESCHENBACH

CIK 1536529 · last filed 2026-05-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.50M

Companies

6

Total Filings

27

Lifetime Open-Market Net

$167.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BLCO Director 86,656 $15.08 $1.31M $99.8K 7 2026-05-28
TLSIW Director $0.75 $0 2 2024-08-21
CELUW Director 336,066 $0.01 $1.9K $0 5 2023-06-16
Radius Health, Inc. (RDUS) Delisted Director 0 $30.00 $0 $0 3 2022-08-15
BHC Director 38,647 $5.06 $195.6K $56.3K 6 2021-08-09
Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Director 3,000 $11.1K 3 2013-08-14

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-05-01 BHC Grant (A) +11,037 $0 EDGAR
2020-03-11 BHC Buy (P) +1,100 $20.0K EDGAR
2019-05-03 BHC Grant (A) +10,633 $250.0K EDGAR
2018-10-31 BHC Grant (A) +5,832 $0 EDGAR
2013-08-14 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Buy (P) +3,000 $11.1K EDGAR
2013-07-05 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Grant (A) $0 EDGAR
2012-07-03 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Grant (A) $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.